Michelle D. Martin
- Oncology top 5%
- Cancer Research top 5%
- Molecular Biology
- Immunology and Allergy top 5%
- Pulmonary and Respiratory Medicine
- Co-authors
- Lynn M. MatrisianConor C. LynchBarbara FingletonTracy Vargo-GogolaMitsuru FutakuchiNoriyasu KawaiTomoyuki ShiraiTodd E. Peterson
- Topics
- Peptidase Inhibition and Analysis (3 papers)Protease and Inhibitor Mechanisms (3 papers)Bone health and treatments (2 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Michelle D. Martin
12 papers receiving 788 citations
Peers
Comparison fields: 5 of 84
- Oncology 499
- Cancer Research 375
- Molecular Biology 348
- Immunology and Allergy 114
- Pulmonary and Respiratory Medicine 88
Countries citing papers authored by Michelle D. Martin
This map shows the geographic impact of Michelle D. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle D. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle D. Martin more than expected).
Fields of papers citing papers by Michelle D. Martin
This network shows the impact of papers produced by Michelle D. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle D. Martin. The network helps show where Michelle D. Martin may publish in the future.
Co-authorship network of co-authors of Michelle D. Martin
This figure shows the co-authorship network connecting the top 25 collaborators of Michelle D. Martin. A scholar is included among the top collaborators of Michelle D. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle D. Martin. Michelle D. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2-advanced breast cancer | 2 |
| 4 | Objective Burden, Resources, and Other Stressors Among Informal Cancer Caregivers | 0 |
| 5 | 10 | |
| 6 | 21 | |
| 7 | 99 | |
| 8 | 14 | |
| 9 | 4 | |
| 10 | 55 | |
| 11 | 239 | |
| 12 | 23 | |
| 13 | 275 | |
| 14 | 51 |
About Michelle D. Martin
Michelle D. Martin is a scholar working on Oncology, Biotechnology and Pharmacy, having authored 14 papers that have together received 796 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Cancer Research (375 citations), Immunology and Allergy (114 citations) and Oncology (499 citations). Michelle D. Martin has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Lynn M. Matrisian, Conor C. Lynch, Barbara Fingleton, Tracy Vargo-Gogola, Mitsuru Futakuchi, Noriyasu Kawai, Tomoyuki Shirai, Todd E. Peterson, Heath B. Acuff and Rakesh K. Singh. Their work appears in journals such as Cancer Cell, Cancer Research and Medical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.